• 1
    Gershon MD. Serotonin and its implication for the management of irritable bowel syndrome. Rev Gastroenterol Disord 2003; 3(2):S2534.
  • 2
    Gershon MD. Plasticity in serotonin control mechanisms in the gut. Curr Opin Pharmacol 2003; 3(6): 6007.DOI: 10.1016/j.coph.2003.07.005
  • 3
    Bayliss WM, Starling EH. The movements and innervation of the small intestine. J Physiol (Lond) 1899; 24: 99143.
  • 4
    Bayliss WM, Starling EH. The movements and innervation of the small intestine. J Physiol (Lond) 1900; 26: 12538.
  • 5
    Bayliss WM, Starling EH. The movements and innervation of the large intestine. J Physiol (Lond) 1900; 26: 10718.
  • 6
    Trendelenburg P. Physiologische und pharmakologische Versuche über die Dünndarm Peristaltick. Naunyn-Schmiedebergs Arch Exp Pathol Pharmakol 1917; 81: 55129.
  • 7
    Langley JN. The Autonomic Nervous System, Part 1. Cambridge: W. Heffer, 1921.
  • 8
    Gershon MD, Kirchgessner AL, Wade PR. Functional anatomy of the enteric nervous system. In: JohnsonLR, AlpersDH, JacobsonED, WalshJH, eds. Physiology of the Gastrointestinal Tract, 3rd edn. New York: Raven Press, 1994: 381422.
  • 9
    Gershon MD, Rothman TP. Enteric glia. Glia 1991; 4: 195204.
  • 10
    Hanani M, Zamir O, Baluk P. Glial cells in the guinea pig myenteric plexus are dye coupled. Brain Res 1989; 497: 2459.DOI: 10.1016/0006-8993(89)90269-2
  • 11
    Gabella G. On the ultrastructure of the enteric nerve ganglia. Scand J Gastroenterol Suppl 1982; 71: 1525.
  • 12
    Bannerman PG, Mirsky R, Jessen KR. Analysis of enteric neurons, glia and their interactions using explant cultures of the myenteric plexus. Dev Neurosci 1987; 9: 20127.
  • 13
    Furness JB, Costa M. The Enteric Nervous System. New York: Churchill Livingstone, 1987.
  • 14
    Furness JB. Types of neurons in the enteric nervous system. J Auton Nerv Syst 2000; 81(1–3): 8796.DOI: 10.1016/S0165-1838(00)00127-2
  • 15
    Furness JB, Sanger GJ. Gastrointestinal neuropharmacology: identification of therapeutic targets. Curr Opin Pharmacol 2002; 2(6): 60911.DOI: 10.1016/S1471-4892(02)00231-X
  • 16
    Erspamer V. Über den 5-Hydroytryptamin-(Enteramin) Gehalt des Magen-Darmtraktes bei den Wirbelten. Naturwissenschaften 1953; 40: 3189.
  • 17
    Vialli M. Histology of the enterochromaffin cell system. In: ErspamerV, ed. Handbook of Experimental Pharmacology: 5-Hydroxytryptamine and Related Indolealkylamines. New York: Springer-Verlag, 1966: 165.
  • 18
    Erspamer V. Occurrence of indolealkylamines in nature. In: ErspamerV, ed. Handbook of Experimental Pharmacology: 5-Hydroxytryptamine and Related Indolealkylamines. New York: Springer-Verlag, 1966: 13281.
  • 19
    Gershon MD. 5-HT (Serotonin) physiology and related drugs. Curr Opin Gastroenterol 2000; 16: 11320.DOI: 10.1097/00001574-200003000-00004
  • 20
    Wade PR, Tamir H, Kirchgessner AL, Gershon MD. Analysis of the role of 5-HT in the enteric nervous system using anti-idiotypic antibodies to 5-HT receptors. Am J Physiol 1994; 266: G40316.
  • 21
    Wade PR, Westfall JA. Ultrastructure of enterochromaffin cells and associated neural and vascular elements in the mouse duodenum. Cell Tissue Res 1985; 241: 55763.
  • 22
    Bearcroft CP, Perrett D, Farthing MJ. Postprandial plasma 5-hydroxytryptamine in diarrhea predominant irritable bowel syndrome: a pilot study. Gut 1998; 42(1): 426.
  • 23
    Grønstad KO, DeMagistris L, Dählström A, et al. The effects of vagal nerve stimulation on endoluminal release of serotonin and substance P into the feline small intestine. Scand J Gastroenterol 1985; 20: 1639.
  • 24
    Fujimaya M, Okumiya K, Kuwahara A. Immunoelectron microscopic study of the luminal release of serotonin from rat enterochromaffin cells induced by high intraluminal pressure. Histochem Cell Biol 1997; 108: 10513.
  • 25
    Forsberg EJ, Miller RJ. Regulation of serotonin release from rabbit intestinal enterochromaffin cells. J Pharm Exp Ther 1983; 227: 75566.
  • 26
    Nilsson O, Ericson LE, Dahlstrom A, Steinbusch HWM, Ahlman H. Subcellular localization of serotonin immunoreactivity in rat enterochromaffin cells. Histochemistry 1985; 82: 35161.
  • 27
    Nilsson O, Ahlman H, Geffard M, Dahlstrom A, Ericson LE. Bipolarity of duodenal enterochromaffin cells in the rat. Cell Tissue Res 1987; 248: 4954.
  • 28
    Racké K, Reimann A, Schwörer H, Kilbinger H. Regulation of 5-HT release from enterochromaffin cells. Behav Brain Res 1996; 73(1–2): 837.
  • 29
    Iversen L. Neurotransmitter transporters: fruitful targets for CNS drug discovery. Mol Psychiatry 2000; 5(4): 35762.
  • 30
    Fuller RW, Wong DT. Serotonin uptake and serotonin uptake inhibition. Ann NY Acad Sci 1990; 600: 6880.
  • 31
    Blakely RD, Berson HE, Fremeau RT, et al. Cloning and expression of a functional serotonin transporter from rat brain. Nature 1991; 354: 6670.
  • 32
    Ramamoothy S, Bauman AL, Moore KR, et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 1993; 90: 25426.
  • 33
    Hoffman B, Mezey E, Brownstein M. Cloning of a serotonin transporter affected by antidepressants. Science 1991; 254: 57980.
  • 34
    Wade PR, Chen J, Jaffe B, Kassem IS, Blakely RD, Gershon MD. Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci 1996; 16(7): 235264.
  • 35
    Chen J-X, Pan H, Rothman TP, Wade PR, Gershon MD. Guinea pig 5-HT transporter: cloning, expression, distribution and function in intestinal sensory reception. Am J Physiol 1998; 275: G43348.
  • 36
    Chen JJ, Zhishan L, Pan H, et al. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high affinity serotonin transporter (SERT): abnormal intestinal motility and the expression of cation transporters. J Neurosci 2001; 21(16): 634861.
  • 37
    Coates MD, Mahoney CR, Linden DR, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and IBS. Gastroentrology 2004; 126(7): 165764.
  • 38
    Gershon MD, Ross LL. Radioisotopic studies of the binding, exchange, and distribution of 5-hydroxytryptamine synthesized from its radioactive precursor. J Physiol (Lond) 1966; 186: 45176.
  • 39
    Gershon MD, Sherman DL, Pintar JE. Type-specific localization of monoamine oxidase in the enteric nervous system: relationship to 5-hydroxytryptamine, neuropeptides, and sympathetic nerves. J Comp Neurol 1990; 301: 191213.
  • 40
    Li ZS, Pham TD, Tamir H, Chen JJ, Gershon MD. Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation. J Neurosci 2004; 24(6): 13309.
  • 41
    Pan H, Gershon MD. Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine. J Neurosci 2000; 20(9): 3295309.
  • 42
    Kirchgessner AL, Tamir H, Gershon MD. Identification and stimulation by serotonin of intrinsic sensory neurons of the submucosal plexus of the guinea pig gut: activity-induced expression of Fos immunoreactivity. J Neurosci 1992; 12: 23549.
  • 43
    Furness JB, Kunze WA, Bertrand PP, Clerc N, Bornstein JC. Intrinsic primary afferent neurons of the intestine. Prog Neurobiol 1998; 54(1): 118.
  • 44
    Bertrand PP, Kunze WAA, Furness JB, Bornstein JC. The terminals of myenteric intrinsic primary afferent neurons of the guinea pig ileum are excited by 5-HT acting at 5-HT3 receptors. Neuroscience 2000; 101(2): 45969.
  • 45
    Sidhu M, Cooke HJ. Role for 5-HT and ACh in submucosal reflexes mediating colonic secretion. Am J Physiol Gastrointest Liver Physiol 1995; 269(3): G34651.
  • 46
    Cooke HJ, Sidhu M, Wang Y-Z. 5-HT activates neural reflexes regulating secretion in the guinea-pig colon. Neurogastroenterol Motil 1997; 9: 1816.
  • 47
    Grider JR, Jin J-G. Distinct populations of sensory neurons mediate the peristaltic reflex elicited by muscle stretch and mucosal stimulation. J Neurosci 1994; 14: 285460.
  • 48
    Sethi AK, Sarna SK. Contractile mechanisms of canine colonic propulsion. Am J Physiol 1995; 268(3 Part 1): G5308.
  • 49
    Li ZS, Furness JB. Immunohistochemical localization of cholinergic markers in putative intrinsic primary afferent neurons of the guinea pig small intestine. Cell Tissue Res 1998; 294: 3543.
  • 50
    Grider JR. CGRP as a transmitter in the sensory pathway mediating peristaltic reflex. Am J Physiol 1994; 266: G113945.
  • 51
    Grider JR. Neurotransmitters mediating the intestinal peristaltic reflex in the mouse. J Pharmacol Exp Ther 2003; 307(2): 4607.
  • 52
    Song Z-M, Brookes SJH, Costa M. All calbindin-immunoreactive myenteric neurons project to the mucosa of the guinea pig small intestine. Neurosci Lett 1994; 180: 21922.
  • 53
    Li ZS, Furness JB. Inputs from intrinsic primary afferent neurons to nitric oxide synthase-immunoreactive neurons in the myenteric plexus of guinea pig ileum. Cell Tissue Res 2000; 299(1): 18.
  • 54
    Kirchgessner AL, Dodd J, Gershon MD. Markers shared between dorsal root and enteric ganglia. J Comp Neurol 1988; 276: 60721.
  • 55
    Kunze WA, Furness JB, Bornstein JC. Simultaneous intracellular recordings from enteric neurons reveal that myenteric AH neurons transmit via slow excitatory postsynaptic potentials. Neuroscience 1993; 55(3): 68594.
  • 56
    Erde SM, Sherman D, Gershon MD. Morphology and serotonergic innervation of physiologically identified cells of the guinea pig's myenteric plexus. J Neurosci 1985; 5: 61733.
  • 57
    Linden DR, Sharkey KA, Mawe GM. Enhanced excitability of myenteric AH neurones in the inflamed guinea-pig distal colon. J Physiol 2003; 547: 589601.
  • 58
    Linden DR, Sharkey KA, Ho W, Mawe GM. Cyclooxygenase-2 contributes to dysmotility and enhanced excitability of myenteric AH neurones in the inflamed guinea pig distal colon. J Physiol 2004; 557: 191205.
  • 59
    Branchek T, Mawe G, Gershon MD. Characterization and localization of a peripheral neural 5-hydroxytryptamine receptor subtype with a selective agonist, 3H-5-hydroxyindalpine. J Neurosci 1988; 8: 258295.
  • 60
    Mawe GM, Branchek T, Gershon MD. Peripheral neural serotonin receptors. Identification and characterization with specific agonists and antagonists. Proc Natl Acad Sci USA 1986; 83: 9799803.
  • 61
    Mawe GM, Branchek T, Gershon MD. Blockade of 5-HT-mediated enteric slow EPSPs by BRL 24924: gastrokinetic effects. Am J Physiol Gastrointest Liver Physiol 1989; 257: G38696.
  • 62
    Wade P, Branchek TA, Mawe GM, Gershon MD. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons. Am J Physiol 1991; 260: G8090.
  • 63
    Galligan JJ, Pan H, Messori E. Signalling mechanism coupled to 5-hydroxytryptamine4 receptor-mediated facilitation of fast synaptic transmission in the guinea-pig ileum myenteric plexus. Neurogastroenterol Motil 2003; 15(5): 5239.
  • 64
    Pan H, Galligan JJ. 5-HT1A and 5-HT4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons. Am J Physiol 1994; 266: G2308.
  • 65
    Craig DA, Clarke DE. Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine4 receptor. J Pharmacol Exp Ther 1990; 252: 137886.
  • 66
    Liu M-T, Fiorica-Howells E, Gershon MD. Alternative splicing of enteric 5-HT receptors and a patch-clamp analysis of function. Gastroenterology 2003; 124: A342(Abstract).
  • 67
    Fiorica-Howells E, Liu M-T, Ponimaskin EG, et al. Distribution of 5-HT4 receptors in wild-type mice and analysis of intestinal motility in 5-HT4 knockout mice. Gastroenterology 2003; 124: A342(Abstract).
  • 68
    Norman P. Tegaserod (Novartis). IDrugs 2002; 5(2): 1719.
  • 69
    Scott LJ, Perry CM. Tegaserod. Drugs 1999; 58(3): 4916; discussion 497–8.
  • 70
    Camilleri M. Review article: tegaserod. Aliment Pharmacol Ther 2001; 15: 27789.
  • 71
    Muller-Lissner SA, Fumagalli I, Bardhan KD, et al. Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001; 15(10): 165566.
  • 72
    Prather CM, Camilleri M, Zinsmeister AR, McKinzie S, Thomforde G. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000; 118(3): 4638.
  • 73
    Camilleri M, Talley NJ. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil 2004; 16(2): 13542.
  • 74
    Nyhlin H, Bang C, Elsborg L, et al. A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome. Scand J Gastroenterol 2004; 39: 11926.
  • 75
    Smith GP, Jerome C, Norgren R. Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats. Am J Physiol 1985; 249: R63841.
  • 76
    Hoffman HH, Schnitzlein HN. The number of vagus nerves in man. Anat Rec 1969; 139: 42935.
  • 77
    Sengupta JN, Gebhart GF. Gastrointestinal afferent fibers and sensation. In: JohnsonLR, AlpersDH, JacobsonED, WalshJH, eds. Physiology of the Gastrointestinal Tract, 3rd edn. New York: Raven Press, 1994: 483520.
  • 78
    Clark KB, Naritoku DK, Smith DC, Browning RA, Jensen RA. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nature Neurosci 1999; 2(1): 948.
  • 79
    George MS, Sackeim HA, Rush AJ, et al. Vagus nerve stimulation: a new tool for brain research and therapy [see comments]. Biol Psychiatry 2000; 47(4): 28795.
  • 80
    Van Laere K, Vonck K, Boon P, Brans B, Vandekerckhove T, Dierckx R. Vagus nerve stimulation in refractory epilepsy: SPECT activation study. J Nucl Med 2000; 41(7): 114554.
  • 81
    Rosenbaum JF, Heninger G. Vagus nerve stimulation for treatment-resistant depression [editorial; comment]. Biol Psychiatry 2000; 47(4): 2735.
  • 82
    Hillsley K, Grundy D. Sensitivity to 5-hydroxytryptamine in different afferent subpopulations within mesenteric nerves supplying the rat jejunum. J Physiol (Lond) 1998; 509: 71727.
  • 83
    Blackshaw LA, Grundy D. Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret. J Auton Nerv Syst 1993; 45(1): 4150.
  • 84
    Hillsley K, Kirkup AJ, Grundy D. Direct and indirect actions of 5-hydroxytryptamine on the discharge of mesenteric afferent fibers innervating the rat jejunum. J Physiol (Lond) 1998; 506: 55161.
  • 85
    Camilleri M, Mayer EA, Drossman DA, et al. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther 1999; 13(9): 114959.
  • 86
    Gregory RE, Ettinger DS. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy. Drugs 1998; 55: 173189.
  • 87
    Rudd JA, Naylor RJ. Effects of 5-HT3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret. Neuropharmacology 1994; 33(12): 16078.
  • 88
    Glatzle J, Sternini C, Robin C, et al. Expression of 5-HT3 receptors in the rat gastrointestinal tract. Gastroenterology 2002; 123(1): 21726.
  • 89
    Raybould HE, Glatzle J, Robin C, et al. Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Am J Physiol Gastrointest Liver Physiol 2003; 284(3): G36772.
  • 90
    Galligan JJ. Electrophysiological studies of 5-hydroxytryptamine receptors on enteric neurons. Behav Brain Res 1996; 73: 199201.
  • 91
    Galligan JJ. Mechanisms of excitatory synaptic transmission in the enteric nervous system. Tokai J Exp Clin Med 1998; 23(3): 12936.
  • 92
    Galligan JJ, LePard KJ, Schneider DA, Zhou X. Multiple mechanisms of fast excitatory synaptic transmission in the enteric nervous system. J Auton Nerv Syst 2000; 81(1–3): 97103.
  • 93
    Galligan JJ. Pharmacology of synaptic transmission in the enteric nervous system. Curr Opin Pharmacol 2002; 2(6): 6239.
  • 94
    Bertrand PP, Furness JB, Bornstein JC. 5-HT and ATP stimulate the mucosal terminals of some myenteric sensory neurons and cause increases in excitability in a population of sensory neurons. In: KrammerHJ, SingerMV, eds. Falk Symposium No 112. . Neurogastroenterology — From the Basics to the Clinics, 1999, Freiburg, Germany.Dordrecht: Kluwer Academic Publishers, 1999: 23 .
  • 95
    Monro RL, Bertrand PP, Bornstein JC. ATP and 5-HT are the principal neurotransmitters in the descending excitatory reflex pathway of the guinea-pig ileum. Neurogastroenterol Motil 2002; 14(3): 25564.
  • 96
    Kadowaki M, Wade PR, Gershon MD. Participation of 5-HT3, 5-HT4, and nicotinic receptors in the peristaltic reflex of the guinea pig distal colon. Am J Physiol 1996; 271: G84957.
  • 97
    Nagakura Y, Kontoh A, Tokita K, Tomoi M, Shimomura K, Kadowaki M. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice. J Pharmacol Exp Ther 1997; 281(1): 28490.
  • 98
    Mangel AW, Northcutt AR. Review article. the safety and efficacy of alosetron, a 5-HT3 receptor antagonist, in female irritable bowel syndrome patients. Aliment Pharmacol Ther 1999; 13(Suppl. 2): 7782.
  • 99
    Beck IT. Possible mechanisms for ischemic colitis during alosetron therapy. Gastroenterology 2001; 121(1): 2312.
  • 100
    Friedel D, Thomas R, Fisher RS. Ischemic colitis during treatment with alosetron. Gastroenterology 2001; 120(2): 55760.
  • 101
    Coffin B, Farmachidi JP, Rueegg P, Bastie A, Bouhassira D. Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects. Aliment Pharmacol Ther 2003; 17(4): 57785.
  • 102
    Camilleri M. What's in a name? Roll on Rome II [editorial]. Gastroenterology 1998; 114(2): 237.
  • 103
    Talley NJ. Irritable bowel syndrome: disease definition and symptom description. Eur J Surg Suppl 1998; 583: 248.
  • 104
    Kay L, Jorgensen T, Lanng C. Irritable bowel syndrome: which definitions are consistent? J Intern Med 1998; 244(6): 48994.
  • 105
    Linden DR, Chen JX, Gershon MD, Sharkey KA, Mawe GM. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2003; 285(1): G20716.
  • 106
    Coates MD, Moses PL, Mahoney CR, et al. Serotonin signaling in the mucosa of the human colon. Gastroenterology 2003; 124(Suppl. 1)(4): A341(Abstract).
  • 107
    Liu MT, Rayport S, Jiang Y, Murphy DL, Gershon MD. Expression and function of 5-HT3 receptors in the enteric neurons of mice lacking the serotonin transporter. Am J Physiol Gastrointest Liver Physiol 2002; 283(6): G1398411.